• Ruxolitinib

    Ruxolitinib

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Ruxolitinib Myelofibrosis Novartis Julaị 6, 2024
  • Crisaborole

    Crisaborole

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Crisaborole Atopic dermatitis na eczema Pfizer Ọnwa Isii 11, 2026 
  • Relugolix

    Relugolix

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Relugolix Ọrịa prostate Takeda na ASKA Ọnwa Mbụ 24, 2024
  • Vericiguat

    Vericiguat

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Vericiguat Obi mgbawa Bayer na MSD Mee.Ọktoba 24, 2031
  • Abrocitinib

    Abrocitinib

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Abrocitinib Atopic dermatitis Pfizer Febụwarị 11, 2034
  • Rimegepant

    Rimegepant

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Rimegepant Isi ọwụwa migraine Biohaven Febụwarị 22, 2031

     

  • Elagolix 834153-87-6

    Elagolix 834153-87-6

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    ElagolixCAS:834153-87-6 Endometriosis N'ime ụlọ      
  • Relugolix 737789-87-6

    Relugolix 737789-87-6

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Ribociclib CAS: 737789-87-6 Antineoplastic N'ime ụlọ      
  • Venetoclax 1257044-40-8

    Venetoclax 1257044-40-8

    Aha API Ngosipụta Onye mmepụta ihe Ụbọchị Mmebi Ikikere (US)
    Venetoclax 1257044-40-8 CLL Abvie Ọnwa Isii 27,2031
  • Velpatasvir(PVP)

    Velpatasvir (PVP)

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Velpatasvir (PVP) HCV N'ime ụlọ    
  • Thalidomide

    Thalidomide

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Thalidomide Ọgwụ Oncology USP/EP      
  • Ticagrelor

    Ticagrelor

    Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
    Ticagrelor Ọgwụ mgbochi N'ime ụlọ 28984  
1234Ọzọ >>> Peeji nke 1/4